...
首页> 外文期刊>Neurochemistry International: The International Journal for the Rapid Publication of Critical Reviews, Preliminary and Original Research Communications in Neurochemistry >Upregulation of IRAS/nischarin (I-1-imidazoline receptor), a regulatory protein of mu-opioid receptor trafficking, in postmortem prefrontal cortex of long-term opiate and mixed opiate/cocaine abusers
【24h】

Upregulation of IRAS/nischarin (I-1-imidazoline receptor), a regulatory protein of mu-opioid receptor trafficking, in postmortem prefrontal cortex of long-term opiate and mixed opiate/cocaine abusers

机译:在长期阿片类药物和混合鸦片/可卡因滥用者的后期前期皮层中,IRAS / Nischarin(I-1-咪唑啉受体)是穆阿片类受体贩运的调节蛋白质的调节蛋白质

获取原文
获取原文并翻译 | 示例

摘要

Imidazoline receptor antisera-selected (IRAS)/nischarin, a putative I-1-imidazoline receptor, has recently been shown to regulate mu-opioid receptor (OR) trafficking and resensitisation. To study a possible involvement of this mu-OR regulator in opiate dependence, the present study assessed by Western blot analysis the contents of IRAS/nischarin and mu-OR in total homogenates and subcellular preparations of postmortem human prefrontal cortex (PFC/BA9) of long-term opiate and mixed opiate/cocaine abusers as well as of matched healthy control subjects. In the PFC/BA9 of long-term opiate/cocaine abusers (all subjects together) IRAS/nischarin content was increased (+67%, p < 0.01, n = 11) when compared with matched controls (n = 10). Similar increases were found for the subgroups of opiate (+72%, n = 6) and mixed opiate/cocaine (+61%, n = 5) abusers. IRAS/nischarin immunocontents were also found increased in subcellular membrane preparations (+61%, p < 0.05, n = 10) of PFC/BA9 from opiate addicts. In the same brain samples, the levels of mu-OR were not different to those in control subjects. Based on the increased contents in brains of opiate abusers and the reported function as mu-OR regulator, IRAS/nischarin could represent a new promising target for treatment of opiate use disorder. (C) 2017 Elsevier Ltd. All rights reserved.
机译:最近已显示咪唑啉受体抗血清选定(IRAS)/ Nischarin,推定的I-1-咪唑啉受体,用于调节穆阿片类受体(或)贩运和转化性。为了研究这种MU或调节剂的可能涉及Apiate依赖性,目前的研究通过Western印迹分析评估了IRAS / Nischarin和MU - 或总均匀常产物的含量和亚细胞的后胚胎培养物(PFC / BA9)的亚细胞制剂长期的鸦片和混合的鸦片/可卡因滥用者以及匹配的健康控制受试者。在与匹配的对照相比(n = 10)相比,长期鸦片/可卡因滥用者(全部受试者一起)的PFC / BA9(全部受试者)增加(+ 67%,P <0.01,n = 11)。对Opiape(+ 72%,n = 6)和混合的鸦片/可卡因(+ 61%,n = 5)滥用者的滥用者来说,发现类似的增加。 IRAS / Nischarin免疫联网也发现亚细胞膜制剂(+ 61%,P <0.05,N = 10)的PFC / BA9来自阿片类药物成瘾者。在同一脑样品中,MU - 或与对照受试者中的水平不同。基于阿片患者的大脑中的含量增加和报告的u-mu-or调节剂,IRA / Nischarin可以代表一种治疗阿片类药物障碍的新有希望的目标。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号